AstraZeneca's cancer drug fails to meet main goal in COVID-19 trials
Posted by
www.biotecnika.org
The drugmaker called the results from the study disappointing but said
it remained committed to its clinical trials for its COVID-19 vaccine,
developed in partnership with Oxford University, and its long-acting
antibody combination.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazenecas-cancer-drug-fails-to-meet-main-goal-in-covid-19-trials/articleshow/79189268.cms
Subscribe to:
Post Comments (Atom)
Post a Comment